On Tuesday, Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) opened lower -3.20% from the last session, before settling in for the closing price of $24.06. Price fluctuations for CPRX have ranged from $19.05 to $26.58 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.27%. Company’s average yearly earnings per share was noted 20.46% at the time writing. With a float of $110.45 million, this company’s outstanding shares have now reached $123.26 million.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Catalyst Pharmaceuticals Inc is 10.14%, while institutional ownership is 81.01%. The most recent insider transaction that took place on Dec 12 ’25, was worth 621,920. In this transaction Director of this company sold 26,746 shares at a rate of $23.25, taking the stock ownership to the 2,360 shares. Before that another transaction happened on Dec 12 ’25, when Company’s Director proposed sale 26,746 for $23.25, making the entire transaction worth $621,929.
Catalyst Pharmaceuticals Inc (CPRX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.7 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.55) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.79% during the next five years compared to 34.27% growth over the previous five years of trading.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Trading Performance Indicators
Check out the current performance indicators for Catalyst Pharmaceuticals Inc (CPRX). In the past quarter, the stock posted a quick ratio of 6.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.95. Likewise, its price to free cash flow for the trailing twelve months is 12.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.71, a number that is poised to hit 0.31 in the next quarter and is forecasted to reach 1.79 in one year’s time.
Technical Analysis of Catalyst Pharmaceuticals Inc (CPRX)
Looking closely at Catalyst Pharmaceuticals Inc (NASDAQ: CPRX), its last 5-days average volume was 0.74 million, which is a drop from its year-to-date volume of 1.35 million. As of the previous 9 days, the stock’s Stochastic %D was 37.75%.
During the past 100 days, Catalyst Pharmaceuticals Inc’s (CPRX) raw stochastic average was set at 69.62%, which indicates a significant increase from 37.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.70 in the past 14 days, which was higher than the 0.66 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.67, while its 200-day Moving Average is $22.23. However, in the short run, Catalyst Pharmaceuticals Inc’s stock first resistance to watch stands at $23.96. Second resistance stands at $24.62. The third major resistance level sits at $25.00. If the price goes on to break the first support level at $22.92, it is likely to go to the next support level at $22.54. Should the price break the second support level, the third support level stands at $21.88.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Key Stats
There are currently 122,912K shares outstanding in the company with a market cap of 2.86 billion. Presently, the company’s annual sales total 491,730 K according to its annual income of 163,890 K. Last quarter, the company’s sales amounted to 148,390 K and its income totaled 52,780 K.
